News

The FDA has approved an expanded indication of the Gore Cardioform Septal Occluder. | Read More

The association between time to endovascular treatment and functional outcome in patients with acute ischemic stroke may be stronger than previously suggested. | Read More

The FDA has approved an expanded indication of the Vascade Vascular Closure System, according to an announcement by Cardiva Medical. | Read More

Varicose veins are significantly associated with risk of developing deep vein thrombosis (DVT), researchers reported in JAMA. | Read More

The authors followed the 12 month outcomes of 101 patients at 17 centers who participated in the OPTALYSE PE study in which the patients were randomized one of four cohorts. | Read More

Current recommendations say that patients are eligible for thrombectomy within 6 hours of a stroke, but newly released results from the DEFUSE 3 trial suggest that the window of opportunity may extend up to 16 hours in certain patients. | Read More

Using certain clinical and anatomic features as a guide, it may be possible to predict whether patients with medically managed type B aortic dissection (TBAD) will benefit from early TEVAR. | Read More

The catheter is indicated for treatment of peripheral arterial disease (PAD), and it is designed to aid in true lumen passage of lesions, both above and below the knee, in the peripheral vasculature. | Read More

Building on the initial results of the MAJESTIC trial, researchers examined treatment durability at the 3-year mark. | Read More

A study published in Circulation has shown for the first time that an acute DNA damage response occurs in operators performing fluoroscopically-guided interventions such as endovascular aortic repair (EVAR). | Read More